Matthews
R, Franceschi D, and Cabahug C. “Abdominal Muscle Uptake on FDG PET Secondary
to Multiple Rib Fractures and Use of Accessory Muscles of Respiration.” Clin
Nucl Med 2005;30:333-34.
Matthews
R. “Before the Fallout: From Marie Curie to Hiroshima.” J Nucl Med 2006;47:896.
Matthews
R. “Voices from Chernobyl: The Oral History of a Nuclear Disaster.” J Nucl Med
2006;47: 1389-90.
Matthews
R. “Classic Feynman: All the Adventures of a Curious Character.” J Nucl Med
2006;47:1391-92.
Matthews
R and Relan N. “Quantitation in Biomedical Imaging with PET and MRI.” J Nucl
Med.2006;47:1728-29.
Matthews
R. “Contact Wounds: A War Surgeon’s Education.” J Nucl Med 2006;47:2066-67.
Matthews
R, Franceschi D, Wenlang X, Cabahug C, Schuman G, Bernstein R, and Peyster R.
“Parietal Lobe Epileptic Focus Identified on SPECT-MRI Fusion Imaging in a Case
of Epilepsia Partialis Continua.” Clin Nucl Med. 2006;31:826-828.
Matthews
R and Relan N. “CT Teaching Manual: A Systemic Approach to CT Reading.” J Nucl
Med 2007;48:494.
Matthews
R. “The Curies: A Biography of the Most Controversial Family in Science.” J
Nucl Med 2007;48:1224.
Matthews
R and Matthews R. “Every Second Counts: The Race to Transplant the First Human
Heart.” J Nucl Med 2007;48:1571-72.
Matthews
R. “Beyond Knowing: Mysteries and Messages of Death and Life from a Forensic
Pathologist.” J Nucl Med 2007;48:1749.
Matthews
R and Relan N. “Advances in Healthcare Technology: Shaping the Future of
Medical Care.” J Nucl Med 2008;49:336.
Matthews
R and Matthews R. “Health Care Meltdown: Confronting the Myths and Fixing Our
Failing System.” J Nucl Med 2008;49:1564-55.
Matthews
R. “Hooked: Ethics, the Medical Profession, and the Pharmaceutical Industry.” J
Nucl Med 2008;49:2068-69.
Matthews
R, Kudelka A, and Kaloudis E. “Visual Vignette. Metastatic Neuroendocrine Tumor.”
Endocrine Practice 2008;14:1065.
Shrestha
P and Matthews R. “Radiologic Clinics: Imaging of Lymphoma.” J Nucl Med.
2009;50:1740-41.
Goodman
M and Matthews R. “The Road to Yucca Mountain: The Development of Radioactive
Waste Policy in the United States.” J Nucl Med. 2010;51:819-20.
Matthews
R, Shrestha P, Franceschi D, Relan N, and Kaloudis E. “Head and Neck Cancers:
Post-Therapy Changes in Muscles with FDG PET-CT.” Clin Nucl Med. 2010;35:494-498.
Kim
HR and Matthews R. “Safe Patients, Smart Hospitals: How One Doctor’s Checklist Can
Help Us Change Health Care from the Inside Out.” J Nucl Med 2010;52:162-163.
Carcamo
CJ and Matthews R. “The Fever: How Malaria has Ruled Humankind for 500,000
Years.” J Nucl Med. 2012;53:343-344.
Franceschi
AM and Matthews R. “Diagnostic Imaging. Musculoskeletal: Non-Traumatic
Disease.” J Nucl Med. 2012;53:658-659.
Franceschi
AM, Matthews R, Mankes S, Safaie E, and Franceschi D. “Four Chamber FDG Uptake
in the Heart: An Indirect Sign of Pulmonary Embolism.” Clin Nucl Med. 2012;37:687-91.
Matthews
R, Bench T, Meng H, Franceschi D, Relan N, and Brown DL. “Diagnosis and
Monitoring of Cardiac Sarcoidosis with Delayed-Enhanced MRI and 18F-FDG
PET-CT.” J Nucl Cardiol. 2012;19:807-810.
Goldberg
M, Matthews R, Meng H, Bilfinger T, and Kort S. “Evaluation of Cardiac
Involvement with Mediastinal Lymphoma: The Role of Innovative Integrated
Cardiovascular Imaging” Echocardiography 2012;29:E189-92.
Matthews
R, Schuster M, Safaie E, Relan N, and Franceschi D. “Fluorodeoxyglucose PET-CT
Findings Following Bone Marrow Harvesting.” World J Nucl Med. 2012;11:19-21.
Moore
W, Freiberg E, Bishawi M, Halbriener M, Matthews R, Bilfinger T, and Baram D.
“FDG-PET Imaging in Patients with Carcinoid Tumor of the Lung.” Clin Nucl Med.
2013;38:501-5.
Matthews
R, Goodman M, Relan, P, Safaie E, and Franceschi D. Tc-99m Mebrofenin
Hepatobiliary Scan in Obstructive Hepatobiliary Disease: Determining Causes
with Early and Late Delayed Imaging. World J Nucl Med 2013. Accepted for
publication.
Vu
CC, Matthews R, Kim B, Franceschi D, Bilfinger TV, and Moore WH. “Prognostic
Value of Metabolic Tumor Volume and Total Lesion Glycolysis from 18F-FDG PET/CT
in Patients Undergoing Stereotactic Body Radiation Therapy for Stage I
Non-Small-Cell Lung Cancer.” Nucl Med Comm 2013. Accepted for publication.
ABSTRACTS
Matthews R, Youssef IM, Bukala K, Quispe M, Kim CK, Krynyckyi
BR, and Machac J. “Reproducibility of Coronary Flow Reserve (CFR)
Measurements with Rubidium-82 PET Perfusion Imaging.” Clin Nucl Med
2005;30:373.
Youssef IM, Travis AR, Matthews R, Almeida O, Krynycki BR, Kim
CK, and Machac J. “Localization of Disease in Patients with Coronary
Artery Disease with Rubidium-82 Stress and Rest PET Myocardial
Perfusion Imaging.” Society of Nuclear Medicine, 52rd Annual
Meeting, Toronto, June 2005. No. 885. Selected by Dr. Wagner in
Highlights Lecture at end of meeting.
Machac J, Matthews R, Almeida O, Youssef IM, Krynyckyi BR, Kim
CK, Padilla M, Iannuzzi M, and Teirstein A. “Characterization of
Patients at Risk of Cardiac Sarcoidosis with PET Stress and Rest
Rubidium-82 and F-18 Fluorodeoxyglucose Imaging.” Society of Nuclear
Medicine, 52rd Annual Meeting, Toronto, June 2005. No. 890.
Youssef IM, Colon D, Rafique A, Sata S, Kim CK, Krynycki BR,
Matthews R, and Machac J. “The Benefit of Two CT Transmission Scans for
Rubidium-82 Cardiac PET Myocardial Perfusion Imaging.” Abstract and
Presentation. Society of Nuclear Medicine, 52rd Annual
Meeting, Toronto, June 2005. No. 331.
Schachter M, Connors P, Mathew J, Naik M, Girard C, Matthews R,
and Stanley W. “Benefits of
SPECT and PET Fusion with Anatomical Modalities.” Abstract and
Presentation. Technologist Section, Greater New York Chapter, Society
of Nuclear Medicine, 35th Annual Meeting, Atlantic City,
March 2006, 2nd Prize
Winner.
Franceschi D, Relan N, Cabahug C, and Matthews R. “Bone Marrow
FDG Uptake in Patients with Extensive Neoplastic Disease at Initial
Presentation.” Abstract and
Presentation. Annual Congress of the European Association of Nuclear
Medicine, Athens, Greece, October 2006. Euro J Nucl. 2006;33(9):S153
Franceschi D, Matthews R, Cabahug C, and Relan N. “Incidental
Foci of Colonic FDG Uptake in Most Cases Represent Premalignant
Adenomas.” 9th Congress of the World Federation of Nuclear
Medicine and Biology. Oct 2006, Seoul, South Korea. Wold J Nucl Med
2006;5(1):S91.
Franceschi D, Relan N, Cabahug C, and Matthews R. “Significance
of Bone Marrow FDG Uptake in Patients with Extensive Neoplastic Disease.”,
9th Congress of the World Federation of Nuclear Medicine and
Biology. Oct 2006, Seoul, South Korea. World J Nucl Med 2006;5(1):S90.
Bevilacqua J, Guevara J, Weiss J, Matthews R, Relan N, Stanley
W, Franceschi D, and Cabahug C. “Evaluation of Co-registration in
Molecular Imaging: PET-PET Fusion.” Abstract and Presentation.
Technologist Section, Greater New York Chapter, Society of Nuclear
Medicine, 36th Annual Meeting, Atlantic City, March 2007, 2nd
Prize Winner.
Matthews R, Relan N, Franceschi D, and Cabahug C. “Follow Up
Malignancies Using Integrated Whole-Body PET Fusion and Subtraction
Techniques.” Abstract. Joint Molecular Imaging Conference, Rhode Island,
September 2007. No. 684.
Franceschi D, Matthews R, Relan N, Weiss J, and Cabahug C.
“Post Radiation Liver Inflammation on FDG PET/CT in Patients Treated
for Distal Esophageal Cancer.” Poster Session. EANM’08 – Annual
Congress of the European Association of Nuclear Medicine, Munich,
Germany, October 2008. Euro J Nucl Med 2008;35(Suppl 2):S273.
Relan N, Matthews R, Franceschi D, and Cabahug C. “PET-CT
Imaging: Factors Affecting Quantification in PET-CT Imaging.” International
Conference on Medical Physics, Radiation Protection and Radiobiology
(ICMPRPR 2K9), Jaipur, India, January 2009.
Goodman M, Matthews R, Relan N, Safaie E, and Franceschi D.
“Role of Delayed Tc-99m Mebrofenin Scanning in Evaluating Obstructive
Hepatobiliary Disease.” Society of Nuclear Medicine 57th
Annual Meeting, Salt Lake City, Utah, June 5-9, 2010. J Nucl Med
2010;51(Supplement 2):1584.
Franceschi D, Matthews R, Relan N, and Safaie E. “Increased FDG
Uptake by the Bone Marrow in Some
Patients with Newly Diagnosed Cancer.” World J Nucl
Med. 2010;9:S153.
Relan N, Matthews R, and Franceschi D. “Regulatory Issues in Investigational Radiopharmaceuticals for Drug Development in the United
States.” 1st World Congress on Gallium-68 and Peptide Receptor Radionuclide
Therapy (PRRNT), Zentralklinik Bad Berka, Germany, June 23-26, 2011.
Moore W, Matthews R,
Hovnanian M, Weir J, Santos T, and Bilfinger T. “FDG-PET Imaging
Findings Post Cryoablation of Patients with Primary Stage 1 Lung Cancer.”
Scientific Formal Presentation, Interventional Oncology Series: Lung Cancer Session.
RSNA 2011, Chicago, IL, November 28, 2011.
Franceschi D,
Matthews R, Relan N, Safaie E, and Weiss T. “Thyroid Stunning as Effect of
Radioiodine Ablation Therapy.” Annual Congress of the European Association of
Nuclear Medicine, Milan, Italy, October 17-31, 2012.
Moore WH, Freidberg
E, Matthews R, Bilfinger T, and Bishawi M. “FDG-PET Imaging in Patients
with Carcinoid Tumor of the Lung.” RSNA 2012, Chicago IL, November 25-30,
2012.
Vu CC, Muath B,
Matthews R, Franceschi D, Bilfinger TV, and Moore WH. “The Predictive
Value of SUVmax on 18F-FDG PET in Early-Stage
Non-Small Cell Lung
Carcinoma.” Society of Nuclear Medicine 2013 Mid-Winter Meeting, New Orleans LA,
January 24-27, 2013.
Chaudhry AA,
Matthews R, and Franceschi D. “Pearls and Pitfalls of I-123 Ioflupane (DATscan)
SPECT Imaging: What the Radiologist and Clinician Need to Know.” ASNR
51st Annual Meeting, San Diego CA, May 18-23, 2013.
Chaudhry AA, Gul, M, Zawin M,
Franceschi D, and Matthews R“Pattern of Benign and Malignant Uptake within
the Abdomen and Pelvis on FDG Positron
Emission Tomography-Computed Tomography.” SNMMI 2013 Annual Meeting at the Vancouver
Convention Centre, Vancouver, BC, Canada, June 8-12, 2013.
Chaudhry AA, Gul, M, Franceschi D, and
Matthews R. “Pearls and Pitfalls of I-123 Ioflupane
(DATscan) SPECT imaging.” SNMMI
2013 Annual Meeting at the Vancouver Convention Centre, Vancouver,
BC, Canada, June 8-12, 2013.
Chaudhry AA, Gul M, Zawin, M, and Matthews R.
“Pearls and Pitfalls of Abdominopelvic Octreotide Imaging: What the
Radiologist and Clinician Need to Know.” SNMMI 2013 Annual Meeting at the Vancouver
Convention Centre, Vancouver, BC, Canada,
June 8-12, 2013.
Matthews R, LoGiurato B,
Safaie E, Moore WH, Bilfinger T, Relan N, and Franceschi D. “FDG PET-CT: Patterns
and Imaging Features Following Percutaneous Cryoablation Treatment for Primary
Non-Small Cell Lung Cancer.” RSNA 2013, Chicago, IL, December 1-6, 2013.
